Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition

Vascular Pharmacology

Volumn 54, Issue 3-6, 2011, Pages 80-87

  Sharma, Saurabh ^a   Singh, Manjeet ^a   Sharma, Pyare Lal ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes mellitus; Endothelial nitric oxide synthetase (eNOS); Hypercholesterolemia; Phosphoinositide dependent kinase (PDK); Protein tyrosine phosphatase (PTPase); Vascular endothelium

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; MESSENGER RNA; NITRATE; NITRITE; PROTEIN TYROSINE PHOSPHATASE; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ACETYLCHOLINE; ANIMALS; ANTICHOLESTEREMIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEPTANOIC ACIDS; HYPERCHOLESTEROLEMIA; MALE; PROTEIN TYROSINE PHOSPHATASES; PYRROLES; RATS; RATS, WISTAR; RNA, MESSENGER; STREPTOZOCIN; VANADATES;

EID: 79957937230     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2010.12.005     Document Type: Article

References (49)

1. Alfonso M., David K., Daan M.F., Van A., Dario R. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 2004, 15:161-170.
2. Allian C.C., Poon L.S., Chan C.S., Richmopnd W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20:470-475.
3. Caramori P.R.A., Zago A.J. Endothelial dysfunction and coronary artery disease. Arq. Bras. Cardiol. 2000, 75:173-182.
4. Chen X., Guan-hua D. Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin. Med. J. 2007, 120(5):421-426.
5. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R.P., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt dependent phosphorylation. Nature 1999, 399:601-605.
6. Dudzinski D.M., Michel T. Life history of eNOS: partners and pathways. Cardiovasc. Res. 2007, 75:247-260.
7. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
8. Elizabeth O., Harrington A.S., Julie N., Gajarah B., Sharon R. Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in endothelial cell apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L342-L353.
9. Endemann H.D., Ernesto L.S. Endothelial dysfunction. J. Am. Soc. Nephrol. 2004, 15:1983-1992.
10. Esper R.J., Roberto A.N., Jorge O.V., Antonio P., José L.C., Rogelio A.M. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc. Diabetol. 2006, 5:4.
11. Faraci F.M., Lentz S.R. Hyperlipidemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345-347.
12. Fleming I., Bauersachs J., Fisslthaler B., Busse R. Ca2-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ. Res. 1998, 82:686-695.
13. Gao N., Ding M., Zheng J.Z., Zhang A., Leonard S.S., Liu K.J., Shi X., Jiang B.H. Vanadate-induced expression of hypoxia inducible factor 1a and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 2002, 277:31963-31971.
14. Gao T., Furnari F., Newton A.C. PHLPP: a Phosphatase that directly dephosphorylates AKT, promotes apoptosis, and suppresses tumor growth. Mol. Cell 2005, 18:13-24.
15. Garcia J.G.N., Schaphorst K.L., Verin A.D., Vepa S., Patterson C.E., Natarajan V. Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J. Appl. Physiol. 2000, 89:2333-2343.
16. Gilbert-McClain L.I., Verin Alexander D., Shi Shu, Irwin Robert P., Garcia Joe G.N. Regulation of endothelial cell myosin light chain phosphorylation and permeability by vanadate. J. Cell. Biochem. 1998, 70:141-155.
17. Goldstein B.J. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr. Drug Targets Immune Endocr. Metab. Disord. 2001, 1:265-275.
18. Harrison D.G. Endothelial control of vasomotion and nitric oxide production. Cardiol. Clin. 1996, 14:1-15.
19. Hartmut R., Stephan F., Hans M., Andreas M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 2001, 108:391-397.
20. Hooft V.H.R., Sauer W.H., Bombrun A., Swinnen D. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem. 2004, 47:4142-4146.
21. Ignarro L.J., Bryns R.E., Buga G.M., Wood K.S., Chaudri G. Pharmacological evidence that endothelium derived relaxing factor is NO: use of Pyragallol and superoxide dismutase to study endothelium dependent and NO-elicited vascular smooth muscle relaxation. J. Pharmacol. Exp. Ther. 1988, 244:181-188.
22. Jakubowski H. Pathophysiological consequences of homocysteine excess. J. Nutr. 2006, 136:1741S-1749S.
23. Jeonga K., Monica M., Kwang K.K., Michael J.Q. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
24. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-K A., Shulman G.I., Neel B.G., Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 2000, 20:5479-5489.
25. Kobayashi T., Matsumoto T., Ooishi K., Kamata K. Differential expression of 2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H135-H143.
26. Liang F., Lee S.Y., Liang J., Lawrence D.S., Zhang Z.Y. The role of protein-tyrosine phosphatase 1B in integrin signaling. J. Biol. Chem. 2005, 280(26):24857-24863.
27. Madsen C.R., King G. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 2006, 3:240-246.
28. Mitra S., Singh M. Possible mechanism of captopril induced endothelium dependent relaxation in isolated rabbit aorta. Mol. Cell. Biochem. 1998, 183:63-67.
29. Molero J.C., Martinez C., Andres A., Satrustegui J., Carrascosa J.M. Vanadate fully stimulates insulin receptor sustrate-1 associated Phosphoinositidyl-3-kinase activity in adipocytes from young and old rats. FEBS Lett. 1998, 425:298-304.
30. Nakagami H., Kaneda Y., Ogihara T., Morishita R. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Hyperlipidemia Rev. I 2005, 59-63.
31. Papapetropoulos A., Fulton D., Lin M.I., Fontana J., McCabe T.J., Zoellner S., Garcia-Cardena G., Zhou Z., Gratton J.P., Sessa W.C. Vanadate is a potent activator of endothelial nitric oxide synthase: evidence for the role of serine/threonine kinase Akt and 90-kDa heat shock protein. Mol. Pharmacol. 2004, 65:407-415.
32. Pieper G.M., Langenstroer P., Siebeneich W. Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc. Res. 1997, 37:145-156.
33. Ramm G., Larance M., Guilhaus M., James D.E. A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the Rab GAP AS160. J. Biol. Chem. 2006, 281:29174-29180.
34. Ruvolo P.P., Clark W., Mumby M., Gao F., May W.S. A Functional role for the B56 alpha subunit of protein phosphatase2A in ceramide regulation of BCL-2 phosphorylation status and function. J. Biol. Chem. 2002, 277:22847-22852.
35. Sastry K.V.H., Moudgal R.P., Mohan J., Tyagi J.S., Rao G.S. Spectrophotometric determination of serum nitrite and nitrate by copper cadmium alloy. Anal. Biochem. 2002, 306:79-82.
36. Sato S., Fujita N., Suruo T. Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine). Oncogene 2002, 21:1727-1738.
37. Schille N.K., Timothy A.M., Chen I.L., Rice R.C., Akers D.L., Kadowitz P.J., McNamaran D.B. Endothelial cell regrowth and morphology after balloon catheter injury of Alloxan-induced diabetic rabbits. Am. J. Physiol. 1999, 277:240-248.
38. Schulz R. Pleiotropic effects of statins: acutely good, but chronically bad?. J. Am. Coll. Cardiol. 2005, 45:1292-1294.
39. Shah D.I., Singh M. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. Vasc. Pharmacol. 2006, 44:177-182.
40. Shah D.I., Singh M. Activation of protein kinase A improves vascular endothelial dysfunction. Endothelium 2006, 13:267-277.
41. Sugano M., Tsuchida K., Makino N.A. Protein tyrosine phosphatase inhibitor accelerates angiogenesis in a rat model of hind limb ischemia. J. Cardiovasc. Pharmacol. 2004, 44:460-465.
42. Toker A., Newton A. Cellular signaling: pivoting around PDK-1. Cell 2000, 103:185-188.
43. Topping R.S., Prasad N., Zhou D., Decker S.J. Oxidative stress and Vanadate induce tyrosine phosphorylation of PDK-1. Biochemistry 2000, 39:6929-6935.
44. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 1969, 6:24-27.
45. Ungavari Z., Pacher P., Rischak K., Szollar L., Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with cholesterol diet induced hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1899-1904.
46. Vercauteren M., Remy E., Devaux C., Dautreaux B., Henry J.-P., Bauer F., Mulder P., Hooft van Huijsduijnen R., Bombrun A., Thuillez C., Richard V. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006, 114:2498-2507.
47. Woodman O.L., Missen M.A., Boujaoude M. Daidzein and 17 bestradiol enhance nitric oxide synthatase activity associated with an increase in calmodulin and a decrease in caveolin-1. J. Cardiovasc. Pharmacol. 2004, 44(2):155-163.
48. Yang G., Wu L., Jiang B., Yang W., Qi J., Cao K., Meng Q., Mustafa A.K., Mu W., Zhang S., Snyder S.H., Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322(5901):587-590.
49. Zulet M.A., Barber A., Garcin H., Martnez J.A. Alteration in carbohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J. Am. Coll. Nutr. 1999, 18:36-42.